Estimates Revisions OSE Immunotherapeutics Börse Stuttgart
Stocks
6OP
FR0012127173
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
15:08:18 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 2.591 EUR | +0.19% |
|
-4.43% | -48.74% |
| 09-20 | OSE Immunotherapeutics SA(ENXTPA:OSE) dropped from S&P Global BMI Index | CI |
| 09-09 | OSE Immunotherapeutics: first patient treated in a Phase 2 study |  |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
OSE Immunotherapeutics(OSE)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
OSE Immunotherapeutics(OSE)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
OSE Immunotherapeutics(OSE)
EBIT
Dividend / Share (DPS)
Data source:
OSE Immunotherapeutics(OSE)
Cash or Net Debt
- Stock Market
- Stocks
- OSE Stock
- 6OP Stock
- Consensus OSE Immunotherapeutics
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
